Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

CRISPR01:59

CRISPR

52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
What is Genetic Engineering?00:49

What is Genetic Engineering?

75.4K
Overview
75.4K
Epigenetic Regulation01:37

Epigenetic Regulation

3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

211
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
211
RNA Editing02:23

RNA Editing

9.2K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Developmental chronology of mouse embryo from 2-cell stage through birth.

Nature cell biology·2026
Same author

PRC2-Related Epigenetic Age Acceleration in Acute Myeloid Leukemia with DNMT3A and IDH2 Mutations.

Advanced biology·2026
Same author

Pathogenicity of Mediator Complex Subunit 27 (MED27) in a Neurodevelopmental Disorder with Cerebellar Atrophy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Genomic Detection and Delineation of Chromoanasynthesis by Mate-Pair Sequencing.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

The indispensable role of Mediator complex subunit 27 during neurodevelopment.

Cell & bioscience·2025
Same author

RNA Mis-Splicing Effects of Noncanonical Splicing Variants in Limb-Girdle Muscular Dystrophy Type R1/2A.

Neurology. Genetics·2025

相关实验视频

Updated: Sep 9, 2025

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

34.4K

基于表观基因组编辑的治疗:进展和挑战

Luowei Yuan1, Yikai Xiong1, Yiming Zhang1

  • 1Division of Biomedical Health Sciences, School of Medicine, The Chinese University of Hong Kong, Shenzhen, 518172, China.

Molecular therapy : the journal of the American Society of Gene Therapy
|September 3, 2025
PubMed
概括
此摘要是机器生成的。

表观基因组编辑精确地修改基因表达而不改变DNA. 本综述涵盖了针对性治疗的DNA甲基化,基因组修饰和转录调节方面的进展.

更多相关视频

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.5K
Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.8K

相关实验视频

Last Updated: Sep 9, 2025

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

34.4K
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.5K
Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.8K

科学领域:

  • 生物技术
  • 遗传学
  • 分子生物学

背景情况:

  • 在没有改变DNA序列的情况下,表观基因组编辑提供了精确的基因表达控制.
  • 它代表了从基础研究到临床应用的重大进步.

研究的目的:

  • 审查过去十年间在表观基因组编辑方面的开创性研究,技术进步,专利和临床试验.
  • 提供针对遗传和复杂疾病的表观基因组编辑治疗潜力的见解.

主要方法:

  • 关于表观基因组编辑技术的出版文献的审查.
  • 分析技术进步和专利情况.
  • 对正在进行和已完成的临床试验进行审查.

主要成果:

  • 确定关键策略,包括向的DNA甲基化/脱甲基化,基因组修饰和转录调节.
  • 突出了长期和可逆的基因表达调节的潜力.
  • 研究和开发工作的综合展示了有前途的治疗场景.

结论:

  • 表观基因组编辑是一种具有变革性的临床方法,
  • 持续的研究和开发对于实现表观基因组编辑的全部治疗潜力至关重要.